This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
OR · On-site
Collaborate with the Chief Medical Officer and other Medical Directors in Oncology on the clinical development of ctDNA-based diagnostics. * Lead development and implementation of clinical strategies ...
This is a unique opportunity to step into a high visibility, tumor specific role where you will help drive the adoption and continued growth of Signatera, our first of its kind MRD ctDNA technology ...
This is a unique opportunity to step into a high visibility, tumor specific role where you will help drive the adoption and continued growth of Signatera, our first of its kind MRD ctDNA technology ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field ...
Diagnostics-native fluency: deep, unassisted comfort discussing cell-free DNA (cfDNA), ctDNA dynamics, minimal residual disease (MRD), analytical vs. clinical validity, and decision-impact metrics.
Diagnostics-native fluency: deep, unassisted comfort discussing cell-free DNA (cfDNA), ctDNA dynamics, minimal residual disease (MRD), analytical vs. clinical validity, and decision-impact metrics.
Senior Machine Learning Scientist, Agentic AI
OR · Remote
$91K - $124K/yr
Leveraging a proprietary data moat of over 250,000 oncology patients profiled with longitudinal ctDNA, WES/WGS, digital pathology, and EMR data, you will design and deploy production-grade autonomous ...
New
Senior Machine Learning Scientist, Agentic AI
OR · Remote
$91K - $124K/yr
Leveraging a proprietary data moat of over 250,000 oncology patients profiled with longitudinal ctDNA, WES/WGS, digital pathology, and EMR data, you will design and deploy production-grade autonomous ...
New
Financial Analyst (Temp)
Fremont, CA · On-site
$70K - $80K/yr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Financial Analyst (Temp)
Fremont, CA · On-site
$70K - $80K/yr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Financial Analyst (Temp)
Fremont, CA · Hybrid
$70K - $80K/yr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
New
Financial Analyst (Temp)
Fremont, CA · Hybrid
$70K - $80K/yr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
New
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Technical Writer - NGS & LIMS Implementation (Temp)
Fremont, CA · Hybrid
$60 - $75/hr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Technical Writer - NGS & LIMS Implementation (Temp)
Fremont, CA · Hybrid
$60 - $75/hr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Machine Learning Scientist, Multimodal AI
San Carlos, CA · On-site +1
$124K - $156K/yr
Technical familiarity with DNA sequencing, RNA sequencing, methylation, and ctDNA assays * Hands-on experience with digital pathology software and whole-slide imaging analysis * Exposure to survival ...
Quick apply
Machine Learning Scientist, Multimodal AI
San Carlos, CA · On-site +1
$124K - $156K/yr
Technical familiarity with DNA sequencing, RNA sequencing, methylation, and ctDNA assays * Hands-on experience with digital pathology software and whole-slide imaging analysis * Exposure to survival ...
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification ...
Deep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc. * Experience directly interfacing in meetings and written ...
Deep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc. * Experience directly interfacing in meetings and written ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Experience in both pharma and Dx settingsDeep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.Experience ...
Technical Writer - NGS & LIMS Implementation (Temp)
Fremont, CA · On-site
$60 - $75/hr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Technical Writer - NGS & LIMS Implementation (Temp)
Fremont, CA · On-site
$60 - $75/hr
... ctDNA) at very low levels (down to ~1-3 PPM) in blood samples. To enable cancer and population sequencing, Personalis' Clinical Laboratory was built with a focus on clinical accuracy, quality, big ...
Ctdna information
What is the difference between Ctdna vs ctDNA?
| Aspect | Ctdna | ctDNA |
|---|---|---|
| Definition | Circulating tumor DNA (Ctdna) refers to tumor-derived DNA fragments found in the bloodstream. | Circulating tumor DNA (ctDNA) is the same as Ctdna, representing tumor DNA fragments in blood. |
| Usage | Used in cancer detection, monitoring treatment response, and minimal residual disease. | Used similarly for cancer detection, prognosis, and treatment monitoring. |
| Work Environment | Laboratories performing liquid biopsies and molecular diagnostics. | Same as Ctdna, in clinical labs and research settings. |
| Certifications | Requires molecular biology, genetics, or pathology certifications. | Same certifications as Ctdna, often overlapping. |
Both Ctdna and ctDNA refer to tumor-derived DNA fragments circulating in the blood, used interchangeably in clinical and research settings for cancer diagnostics and monitoring.

Other
Posted 17 days ago
Natera rating
7.7
Based on 35 frontline employees who took The Breakroom Quiz
47th of 103 rated laboratories
Job description
LOCATION: This role will cover Northern Texas. Ideally we are looking for someone in Dallas or Fort Worth, Texas.
We're looking for a dynamic Clinical Oncology Specialist (COS) to join our newly established Breast Oncology specialty team. This is a high-impact, tumor-specific role focused on accelerating the adoption and growth of Signatera-our groundbreaking, first-in-class MRD ctDNA test. As a COS, you'll act as a strategic field partner and a key representative of Natera Oncology, collaborating cross-functionally to engage key opinion leaders (KOLs) across integrated delivery networks, academic medical centers, hospital systems, and select community oncology practices.
Primary stakeholders include Breast Surgeons, Breast Radiologists, Radiation Oncologist, Medical Oncologists and Pathologists. Success in this role demands a deep understanding of the breast oncology space, strong clinical acumen, and the ability to navigate complex healthcare systems while fostering trusted, value-driven relationships.
We're seeking individuals who thrive in a fast-paced, entrepreneurial environment and are driven by purpose, passion, and the pursuit of clinical excellence. Frequent travel is required.
Key Responsibilities
- Develop and execute a strategic territory plan focused on growth and account penetration
- Identify and engage KOLs and key accounts to integrate Signatera into clinical decision-making
- Drive new business development while expanding and deepening existing relationships
- Maximize return on investment through consistent sales activity and cross-functional collaboration
- Deliver impactful clinical education to physicians and care teams
- Serve as a trusted resource in a fast-paced, startup-like environment
- Build deep understanding of Natera's oncology solutions, internal processes, and competitor landscape
- Call on targeted physicians and practices to promote Natera's oncology products and services
- Drive product adoption by influencing clinical decision-making at the provider and system level
- Monitor account performance and market trends; escalate issues and identify new opportunities
- Consistently conduct business in an ethical, transparent, and professional manner
Qualifications
- Bachelor's degree required
- 5+ years of successful experience in breast oncology, surgical sales, or molecular diagnostics preferred
- Deep knowledge of academic and community oncology markets, precision medicine, and reimbursement landscape
- Ability to travel frequently, including overnight travel as needed
- Valid driver's license and safe driving record
- Proven leadership, business acumen, and strong communication skills
- Travel: ~75% (combination of road and air travel)
Key Competencies
- Excellent verbal, written, and presentation skills
- Strategic, forward-thinking, and data-driven mindset
- Ability to work independently and collaboratively in team environments
- Strong clinical understanding of oncology and molecular diagnostics
- Comfortable navigating complex healthcare systems and engaging senior stakeholders.
Total compensation includes a competitive base salary and uncapped quarterly commissions. In addition we offer a car allowance and Restricted Stock Units (RSUs).